These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 11417444

  • 1. Human thiopurine S-methyltransferase activity in uremia and after renal transplantation.
    Weyer N, Kröplin T, Fricke L, Iven H.
    Eur J Clin Pharmacol; 2001 May; 57(2):129-36. PubMed ID: 11417444
    [Abstract] [Full Text] [Related]

  • 2. Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).
    Zhang LR, Song DK, Zhang W, Zhao J, Jia LJ, Xing DL.
    Clin Chim Acta; 2007 Feb; 376(1-2):45-51. PubMed ID: 16952345
    [Abstract] [Full Text] [Related]

  • 3. Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.
    Dervieux T, Médard Y, Baudouin V, Maisin A, Zhang D, Broly F, Loirat C, Jacqz-Aigrain E.
    Br J Clin Pharmacol; 1999 Dec; 48(6):793-800. PubMed ID: 10594482
    [Abstract] [Full Text] [Related]

  • 4. Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation.
    Schütz E, Gummert J, Armstrong VW, Mohr FW, Oellerich M.
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):199-205. PubMed ID: 8721407
    [Abstract] [Full Text] [Related]

  • 5. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients.
    Chocair PR, Duley JA, Simmonds HA, Cameron JS.
    Transplantation; 1992 May; 53(5):1051-6. PubMed ID: 1585469
    [Abstract] [Full Text] [Related]

  • 6. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [Abstract] [Full Text] [Related]

  • 7. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S, Angsuthum S, Avihingsanon Y, Sirivongs D, Pongskul C, Makarawate P, Praditpornsilpa K, Tassaneeyakul W, Tassaneeyakul W.
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.
    Chrzanowska M, Kurzawski M, Droździk M, Mazik M, Oko A, Czekalski S.
    Pharmacol Rep; 2006 Jul; 58(6):973-8. PubMed ID: 17220558
    [Abstract] [Full Text] [Related]

  • 9. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors.
    Pazmiño PA, Sladek SL, Weinshilboum RM.
    Clin Pharmacol Ther; 1980 Sep; 28(3):356-67. PubMed ID: 7408396
    [Abstract] [Full Text] [Related]

  • 10. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK, Zhao J, Zhang LR.
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [Abstract] [Full Text] [Related]

  • 11. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
    Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR.
    Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
    [Abstract] [Full Text] [Related]

  • 12. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.
    Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE.
    Ann Intern Med; 1997 Apr 15; 126(8):608-14. PubMed ID: 9103127
    [Abstract] [Full Text] [Related]

  • 13. Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients.
    Mircheva J, Legendre C, Soria-Royer C, Thervet E, Beaune P, Kreis H.
    Transplantation; 1995 Oct 15; 60(7):639-42. PubMed ID: 7570968
    [Abstract] [Full Text] [Related]

  • 14. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
    Fabre MA, Jones DC, Bunce M, Morris PJ, Friend PJ, Welsh KI, Marshall SE.
    Transpl Int; 2004 Oct 15; 17(9):531-9. PubMed ID: 15349717
    [Abstract] [Full Text] [Related]

  • 15. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.
    Arch Dermatol; 2008 Sep 15; 144(9):1143-7. PubMed ID: 18794458
    [Abstract] [Full Text] [Related]

  • 16. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
    Kurzawski M, Dziewanowski K, Lener A, Drozdzik M.
    Eur J Clin Pharmacol; 2009 May 15; 65(5):533-40. PubMed ID: 19229528
    [Abstract] [Full Text] [Related]

  • 17. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
    Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM.
    Clin Pharmacol Ther; 1987 Jan 15; 41(1):18-25. PubMed ID: 3467886
    [Abstract] [Full Text] [Related]

  • 18. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
    Snow JL, Gibson LE.
    Arch Dermatol; 1995 Feb 15; 131(2):193-7. PubMed ID: 7857117
    [Abstract] [Full Text] [Related]

  • 19. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H.
    Ther Drug Monit; 2012 Dec 15; 34(6):695-701. PubMed ID: 23149442
    [Abstract] [Full Text] [Related]

  • 20. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
    Evans WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R, Kalwinsky D, Keller F, Khatib Z, Margolin J, Murray J, Quinn J, Ravindranath Y, Ritchey K, Roberts W, Rogers ZR, Schiff D, Steuber C, Tucci F, Kornegay N, Krynetski EY, Relling MV.
    J Clin Oncol; 2001 Apr 15; 19(8):2293-301. PubMed ID: 11304783
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.